Advisory Board November 13, 2024
Although the side effects of GLP-1 drugs, which are used for diabetes and weight loss, are typically mild, some patients have reported more severe issues, including stomach paralysis and gallbladder damage. As more reports of severe GLP-1 side effects emerge, thousands of patients are filing lawsuits against GLP-1 manufacturers.
Resource library: Weight management and obesity care
GLP-1 manufacturers face dozens of lawsuits
GLP-1 drugs, which are used to treat diabetes and weight loss, have surged in popularity in recent years, with data showing that 40 times more GLP-1 prescriptions were written in 2023 compared to 2018. Two major manufacturers of the drugs are Novo Nordisk, which makes Ozempic, Wegovy, and Rybelsus, and Eli Lilly, which makes Trulicity, Mounjaro, and Zepbound.
...